NanoBio Corporation Presents Preclinical And Interim Clinical Data On Topical Treatments For Herpes Labialis And Onychomycosis At AAD 2008
NanoBio Corporation is presenting safety and efficacy results on new topical treatments for herpes labialis (cold sores) and onychomycosis (toe nail fungus) at the annual meeting of the American Academy of Dermatology (AAD), being held February 1-5, 2008, in San Antonio.
More: continued here
Filed under: Infectious Diseases / Bacteria / Viruses on February 7th, 2008